The higher a woman's prepregnancy body mass index, the more likely she is to deliver surgically, but not if she is given a higher dose of oxytocin, according to new data.
The higher a woman's prepregnancy body mass index (BMI), the more likely she is to deliver surgically, but not if she is given a higher dose of oxytocin, according to data presented at the Society for Maternal-Fetal Medicine Pregnancy Meeting, February 7-12, 2011, in San Francisco, California.
Researchers from Rochester, New York, presented a retrospective cohort study of all women who underwent labor induction at term at their institution from October 2007 to September 2008. Of 498 women in the study, 81% delivered vaginally and 19% required cesarean delivery. An inverse relationship between increasing prepregnancy BMI and the likelihood of vaginal delivery was noted. Women with a prepregnancy BMI less than 25 kg/m2 had a hazard ratio (HR) for vaginal delivery of 0.98 (95% CI, 0.97-0.99). Those with BMIs between 25.0 kg/m2 and 29.9 kg/m2 (ie, overweight) had an HR for vaginal delivery of 0.80 (95% CI, 0.65-0.98); those with BMIs greater than or equal to 30 kg/m2 (ie, obese) had an HR of 0.79 (95% CI, 0.63-0.98).
Although the same trend occurred in the group given oxytocin 1 mU/min with increases every 45 minutes (ie, for overweight women, HR, 0.66; 95% CI, 0.47-0.92; for obese women, HR, 0.63; 95% CI, 0.44-0.91), it did not occur in the group given a larger dose (2 mU/min with increases every 30 minutes). Overweight women receiving this dose had an HR for vaginal delivery of 0.86 (95% CI, 0.67-1.12); obese women had an HR of 0.90 (95% CI, 0.69 -1.18).
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More